Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
Conditions:   Cognitive Decline;   Intracerebral Hemorrhage;   Dementia, Vascular;   Cerebral Small Vessel Diseases;   Hypertension;   Stroke Hemorrhagic Interventions:   Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2018 Category: Research Source Type: clinical trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) MRI Sub-study
Conditions:   Stroke;   Cerebral Small Vessel Diseases;   Intracerebral Hemorrhage;   Vascular Dementia;   Hypertension Interventions:   Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2018 Category: Research Source Type: clinical trials

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Hypertension Interventions:   Drug: Perindopril and Amlodipine;   Drug: Perindopril-indapamide Sponsors:   Yaounde Central Hospital;   University of Yaounde 1 Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2018 Category: Research Source Type: clinical trials